Structural characterization of human liver heparan sulfate

Biochimica et Biophysica Acta - General Subjects

Volumn 1721, Issue 1-3, 2005, Pages 1-8

  Vongchan, Preeyanat ^a   Warda, Mohamad ^b   Toyoda, Hidenao ^c   Toida, Toshihiko ^c   Marks, Rory M ^d   Linhardt, Robert J ^b,e  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b Cairo University   (Egypt)

^c CHIBA UNIVERSITY   (Japan)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

Glycosaminoglycan; Heparan sulfate; Human liver; Proteoglycan; Structure

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A INHIBITOR; DISACCHARIDE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; HEPARIN LYASE; POLYACRYLAMIDE GEL; PROTEOGLYCAN;

ANIMAL TISSUE; ARTICLE; CARBOHYDRATE ANALYSIS; CONCENTRATION PROCESS; CONTROLLED STUDY; DEPOLYMERIZATION; DERIVATIZATION; ENZYME ACTIVITY; FLUORESCENCE ANALYSIS; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE; ISOLATION PROCEDURE; LIVER; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PURIFICATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY ANALYSIS; STRUCTURE ANALYSIS; SULFATION;

HEPARITIN SULFATE; HUMANS; LIVER; MOLECULAR WEIGHT; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR;

SUIDAE;

EID: 11844304289     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2004.09.007     Document Type: Article

References (41)

1. M. Belting HS proteoglycan as a plasma membrane Trends Biochem. Sci. 28 2003 145 151
2. P.W. Park, O. Reizes, and M. Bernfield Cell surface heparan sulfate proteoglycans: selective regulators of ligand-receptor encounters J. Biol. Chem. 275 2000 29923 29926
3. A.D. Lander, C.S. Stipp, and J.K. Ivins The glypican family of heparan sulfate proteoglycans: major Perspect. Dev. Neurobiol. 3 1996 347 358
4. J. Filmus, and S.B. Sellick Glypicans: proteoglycans with a surprise J. Clin. Invest. 108 2001 497 501
5. E.M. Selva, and N. Perrimon Role of heparan sulfate proteoglycans in cell signaling and cancer Adman. Cancer Res. 83 2001 67 80
6. R.V. Iozzo, and J.D. San Antonio HS proteoglycans: heavy hitters in the angiogenesis arena J. Clin. Invest. 108 2001 349 355
7. R.V. Iozzo Heparan sulfate proteoglycans: intricate molecules with intriguing functions J. Clin. Invest. 108 2001 165 167
8. J. Turnbull, A. Powell, and S. Guimond Heparan sulfate: decoding a dynamic multifunctional cell regulator Trends Cell Biol. 11 2001 75 82
9. J. Dong, C.A. Peters-Libeu, K.H. Weisgraber, B.W. Segelke, B. Rupp, I. Capila, M.J. Hernaiz, L.A. LeBrun, and R.J. Linhardt Interaction of the N-terminal domain of apolipoprotein E4 with heparin Biochemistry 40 2001 2826 2834
10. C. Peters-Libeu, S. Lund-Katz, M. Phillips, S. Wehrli, M.J. Hernaiz, I. Capila, R.J. Linhardt, R. Raffia, Y.M. Newhouse, F. Zhou, and K.H. Weisgraber New insights into the heparan sulfate proteoglycan binding activity of apolipoprotein E4 J. Biol. Chem. 276 2001 39138 39142
11. H.G. Bazin, M.A. Marques, A.P. Owens, R.J. Linhardt, and K.A. Krutcher Inhibition of apolipoprotein E-related neurotoxicity by glycosaminoglycans and their oligosaccharides Biochemistry 41 2002 8203 8211
12. G.M. Castillo, C. Ngo, J. Cummings, T.N. Wight, and A.D. Snow Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability J. Neurohemal. 69 1997 2452 2465
13. Y.L. Lin, H.Y. Lei, Y.S. Lin, T.M. Yeh, S.H. Chen, and H.S. Liu Heparin inhibits dengue-2 virus infection of five human liver cell lines Antivir. Res. 56 2002 93 96
14. G. Pradel, S. Garapaty, and U. Frevert Proteoglycans mediate malaria sporozoite targeting to the liver Mol. Microbiol. 45 2002 637 651
15. H. Barth, C. Schäfer, M.I. Adam, F. Zhang, R.J. Linhardt, E. Della, F. von Weizsacker, H.E. Blum, and T.F. Baumert Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate J. Biol. Chem. 278 2003 41003 41012
16. J. Mc Clean The thromboplastic action of cephalin Am. J. Physiol. 41 1916 250 257
17. M. Lyon, J.A. Dakin, and J.T. Gallagher Liver heparan sulfate structure J. Biol. Chem. 269 1994 11208 11215
18. M.J. Hernáiz, H.O. Yang, N.S. Gunny, and R.J. Linhardt Purification and characterization of heparan sulfate peptidoglycans from bovine liver Carbohydr. Polym. 48 2002 153 160
19. T. Toida, H. Yoshida, H. Toyoda, I. Koshiishi, T. Imanari, R.E. Hillman, J.R. Fromm, and R.J. Linhardt Structural differences and the presence of unsubstituted amino groups in heparan sulfates from different tissues and species Biochem. J. 322 1997 499 506
20. A.A. Horner Rat heparins Biochem. J. 240 1986 171 179
21. H. Kresse, H. Hausser, and R. Schonherr Small proteoglycans Experimenta 49 1993 403 406
22. D. Rathore, T.F. McCutchan, M.J. Hernáiz, L.A. LeBrun, S.C. Lang, and R.J. Linhardt Direct measurement of the interaction of glycosaminoglycans and a heparin hexasaccharide with malaria circumsporozoite protein Biochemistry 40 2001 11518 11524
23. Y. Chen, T. Maguire, R.E. Hillman, J.R. Fromm, J.D. Esko, R.J. Linhardt, and R.M. Marks Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate Nature Med. 3 1997 866 871
24. S. Wellnitz, B. Klumpp, H. Barth, S. Ito, E. Depta, J. Dubuisson, H.E. Blum, and T.F. Baumert Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines J. Virol. 76 2002 1181 1193
25. I. Capila, and R.J. Linhardt Heparin-protein interactions Angew. Chem., Int. Ed. 41 2002 390 412
26. Y. Park, G. Yu, N.S. Gunary, and R.J. Linhardt Purification and characterization of heparan sulfate proteoglycans from bovine liver Biochem. J. 344 1999 723 730
27. M. Warda, E.M. Gouda, T. Toida, L. Chi, R.J. Linhardt, Isolation and characterization of raw heparin from dromedary intestine: evaluation of a new source of pharmaceutical heparin, Comp. Biochem. Physiol.
28. C.C. Griffin, R.J. Linhardt, C.L. Van Gorp, T. Toida, R.E. Hillman, R.L. Schubert, and S.D. Brown Isolation and characterization of heparan sulfate from crude porcine intestinal mucosa peptidoglycan heparin Carbohydr. Res. 276 1995 183 197
29. H. Toyoda, H. Yamamoto, N. Ogino, T. Toida, and T. Imanari Rapid and sensitive analysis of disaccharide composition in heparin and heparan sulfate by reversed-phase ion-pair chromatography on a 2μm porous silica gel column J. Chromatogr., A 830 1999 197 201
30. Y. Liang, M. Haring, P.J. Roughly, R.K. Margolis, and R.U. Margolis Glypican and biglycan in the nuclei of neurons and glioma cells: presence of functional nuclear localization signals and dynamic changes in glypican during the cell cycle J. Cell Biol. 139 1997 851 864
31. K. Gu, J. Liu, A. Pervin, and R.J. Linhardt Comparison of the activity of two chondroitin AC lyases on dermatan sulfate Carbohydr. Res. 244 1993 369 377
32. R.E. Edens, A. Al-Hakim, J.M. Wailer, D.G. Rethwisch, J. Fareed, and R.J. Linhardt Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives J. Pharm. Sci. 81 1992 823 827
33. Z.M. Merchant, Y.S. Kim, K.G. Rice, and R.J. Linhardt Structure of heparin derived tetrasaccharides Biochem. J. 229 1985 369 377
34. J.T. Gallagher, and A. Walker Molecular distinctions between heparan sulfate and heparin. Analysis of sulfation patterns indicates that heparan sulfate and heparin are separate families of N-sulfated polysaccharides Biochem. J. 230 1985 665 674
35. R.J. Linhardt, and T. Toida Role of glycosaminoglycans in cellular communication Accounts Chem. Res. 37 2004 431 438
36. D. WuDunn, and P.G. Spear Initial interaction of herpes simplex virus with cells is binding to heparan sulfate J. Virol. 63 1989 52 58
37. M. Yanagishita Cellular catabolism of heparan sulfate proteoglycans TIGG 10 1998 57 63
38. Y.J. Sung, C.C. Juan, H.C. Lee, P.H. Yin, C.W. Chi, H.H. Ku, A.F. Li, Y.H. Wei, and H.J. Tsay Oxidative stress is insignificant in N1S1-transplanted hepatoma despite markedly declined activities of the antioxidant enzymes, Nocl Reports 6 1999 1313 1319
39. S. Dong-Yun, D. Yu-Ru, L. Shan-Lin, Z. Ya-Dong, and W. Lian Redox stress regulates cell proliferation and apoptosis of human hepatoma through Akt protein phosphorylation FEBS Lett. 542 2003 60 64
40. J.D. Esko, and S.B. Sellick Order out of chaos; assembly of ligand binding sites in heparan sulfate Ann. Rev. Biochem. 71 2002 435 471
41. T. Nakatsura, Y. Yoshitake, S. Senju, M. Monji, H. Komori, Y. Motomura, S. Hosaka, T. Beppu, T. Ishiko, H. Kamohara, H. Ashihara, T. Katagiri, Y. Furukawa, S. Fujiyawa, M. Ogawa, Y. Nakamura, and Y. Nishimura Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor maker Biochem. Biophys. Res. Commun. 306 2003 16 25